Redmond Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Redmond Asset Management's LLY Position: Q1 2026 in Review
Redmond Asset Management reduced its Eli Lilly (LLY) stake by 0.77% in Q1 2026, selling an estimated $10.1K and leaving 1,282 shares worth $1.18M. The position accounts for 0.32% of the portfolio, ranked #99.
Redmond Asset Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.39M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Redmond Asset Management held 1,282 shares of Eli Lilly worth $1.18M as of Q1 2026.
- Redmond Asset Management sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
- Eli Lilly made up 0.32% of Redmond Asset Management's portfolio in Q1 2026, its #99 holding.
- Redmond Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Redmond Asset Management's Eli Lilly position peaked at $1.39M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Redmond Asset Management's 13F filing for Q1 2026, filed 6 May 2026.